Publication | Closed Access

Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis

Rheumatoid DisorderMusculoskeletal ResearchPharmacologyChronic Musculoskeletal ConditionOsteoarthritisNon-operative ManagementMedicineOsteoporosisRheumatoid ArthritisDrug Discovery